CMS-10152 Interpreting Physician Scan Assessment Form

Data collection for Medicare Beneficiaries Receiving FDG Positron Emission Tomography (PET) for Brain, Cervical, Ovarian, Pancreatic, Small Cell Lung, and All Other Cancers

0938-0968 Form 6

Collection for Medicare Bene#s Receiving FDG Positron Emissions Tomography for Brain, Cervical, Ovarian, Small Cell Lung, and Testicular Cancers

OMB: 0938-0968

Document [pdf]
Download: pdf | pdf
Interpreting Physician Scan Assessment Form
National Oncologic PET Registry

F18 Fluoride PET Scan

Interpreting Physician Scan Assessment Form
National Oncologic PET Registry
•
•

This form is used to summarize the findings of the PET bone scan. It should be completed by the
interpreting physician at the time the PET scan is interpreted.
It must be submitted by the PET facility via Web-based data entry within 30 days of completing the
PET scan.

PET FACILITY ID #: _______________________________
REGISTRY CASE #: ______________________________

1. OVERALL ASSESSMENT
 Normal study
 Benign skeletal abnormalities only
 Osseous metastatic disease or primary malignant bone tumor
 Unifocal
 Multifocal
 Diffuse skeletal involvement
If osseous metastatic disease or primary malignant bone tumor selected, indicate level of confidence

 Definitely present
 Probably present
 Equivocal
2. WAS COMPARISON MADE WITH PRIOR RADIONUCLIDE BONE IMAGING?
 Yes
 No
a. If yes, indicate type of study:
 Conventional bone scintigraphy
 F-18 fluoride bone PET
b. Date of prior study
a. Based on the comparison, there has been:
 No change; there is no evidence on prior or current study of metastatic disease
 Resolution of previously seen metastatic disease
 Improvement of previously seen metastatic disease

ClinicalTrials.gov Identifier PENDING

Version: June 17, 2010

Interpreting Physician Scan Assessment Form
National Oncologic PET Registry

F18 Fluoride PET Scan

 No change in previously seen metastatic disease
 Progression of previously seen metastatic disease
3. I HAVE READ THE INTERPRETING PHYSICIAN INFORMATION STATEMENT
AND:
 I DO give my consent for the inclusion of data collected for this patient in NOPR
research.

 I DO NOT give my consent for the inclusion of data collected for this patient in NOPR
research.

4. NAME OF PERSON SUBMITTING THIS FORM
First Name: __________________

Last Name: ______________________

Date:

5. PHYSICIAN ATTESTATION OF DATA ACCURACY
By signing below I verify that, to the best of my knowledge, the information on this form is
accurate.
Physician Signature: _______________________________________________

Date:

Printed Name of Physician: __________________________________________

Thank you for your assistance.
PRA Disclosure Statement
According to the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of
information unless it displays a valid OMB control number. The valid OMB control number for this
information collection is 0938-0968. The time required to complete this information collection is estimated
to average five (5) minutes per response, including the time to review instructions, search existing data
resources, gather the data needed, and complete and review the information collection. If you have
comments concerning the accuracy of the time estimate(s) or suggestions for improving this form, please
write to: CMS, 7500 Security Boulevard, Attn: PRA Reports Clearance Officer, Mail Stop C4-26-05,
Baltimore, Maryland 21244-1850.

ClinicalTrials.gov Identifier PENDING

Version: June 17, 2010


File Typeapplication/pdf
AuthorCMS
File Modified2012-08-29
File Created2012-08-29

© 2024 OMB.report | Privacy Policy